Industry Symposium by Siemens Healthineers and Bayer

IND 3 - Interdisciplinary perspectives in Lung Cancer: advancements in screening modalities and surgical implications

Dive into the forefront of lung cancer management at our symposium, where we explore cutting-edge screening techniques and their direct impact on surgical strategies. Join leading experts in radiology and surgery as they present innovative approaches, fostering a comprehensive dialogue aimed at refining clinical decisions and enhancing patient outcomes. Learn more about advanced diagnostic modalities and surgical interventions designed to maximize precision in lung cancer treatment.

20 min
Lung Cancer Screening – why should we do it?
Isabelle Ayx, München / Germany
Morbidity and Mortality of Lung Cancer worldwide;
Chances and Risks of Lung Cancer Screening (LCS);
risk-based inclusion criteria of LCS.
20 min
What to know about your Lung-RADS score?
Nicola Sverzellati, Parma / Italy
1) To familiarize with the Lung-RADS 2022 categories
2) To focus on the new additions in Lung-RADS 2022
3) To familiarize with the management of benign and malignant nodules
20 min
New frontiers in thoracic surgery – Implications of lung cancer screening on surgical therapy
Isabelle Schmitt-Opitz, Züric / Switzerland
Implications of early detection of lung cancer on thoracic surgery

New approaches and modalities in thoracic surgery

Multidisciplinary set-up to defeat lung cancer

Lectures

1
Lung Cancer Screening – why should we do it?

Lung Cancer Screening – why should we do it?

20:00Isabelle Ayx, München / DE

2
What to know about your Lung-RADS score?

What to know about your Lung-RADS score?

20:00Nicola Sverzellati, Parma / IT

3
New frontiers in thoracic surgery – Implications of lung cancer screening on surgical therapy

New frontiers in thoracic surgery – Implications of lung cancer screening on surgical therapy

20:00Isabelle Schmitt-Opitz, Züric / CH